Global EPA & DHA Omega-3 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global EPA & DHA Omega-3 Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
EPA & DHA Omega-3 report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global EPA & DHA Omega-3 market is projected to reach US$ 114140 million in 2034, increasing from US$ 57980 million in 2022, with the CAGR of 10.0% during the period of 2024 to 2034. Demand from Infant Formula and Fortified Foods and Beverages are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for EPA & DHA Omega-3 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, EPA & DHA Omega-3 key manufacturers include WHC, Viva, OmegaVia, WHC, Nutrigold, Omax3, The, Ocean and InnovixLabs, etc. WHC, Viva, OmegaVia are top 3 players and held % sales share in total in 2022.
EPA & DHA Omega-3 can be divided into Capsule EPA and Powder EPA, etc. Capsule EPA is the mainstream product in the market, accounting for % sales share globally in 2022.
EPA & DHA Omega-3 is widely used in various fields, such as Infant Formula, Fortified Foods and Beverages, Nutritional Supplements and Pharmaceuticals, etc. Infant Formula provides greatest supports to the EPA & DHA Omega-3 industry development. In 2022, global % sales of EPA & DHA Omega-3 went into Infant Formula filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global EPA & DHA Omega-3 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
WHC
Viva
OmegaVia
WHC
Nutrigold
Omax3
The
Ocean
InnovixLabs
Controlled
Segment by Type
Capsule EPA
Powder EPA
Infant Formula
Fortified Foods and Beverages
Nutritional Supplements
Pharmaceuticals
Clinical Nutrition
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the EPA & DHA Omega-3 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of EPA & DHA Omega-3, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the EPA & DHA Omega-3 industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of EPA & DHA Omega-3 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, EPA & DHA Omega-3 introduction, etc. EPA & DHA Omega-3 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of EPA & DHA Omega-3 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for EPA & DHA Omega-3 industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, EPA & DHA Omega-3 key manufacturers include WHC, Viva, OmegaVia, WHC, Nutrigold, Omax3, The, Ocean and InnovixLabs, etc. WHC, Viva, OmegaVia are top 3 players and held % sales share in total in 2022.
EPA & DHA Omega-3 can be divided into Capsule EPA and Powder EPA, etc. Capsule EPA is the mainstream product in the market, accounting for % sales share globally in 2022.
EPA & DHA Omega-3 is widely used in various fields, such as Infant Formula, Fortified Foods and Beverages, Nutritional Supplements and Pharmaceuticals, etc. Infant Formula provides greatest supports to the EPA & DHA Omega-3 industry development. In 2022, global % sales of EPA & DHA Omega-3 went into Infant Formula filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global EPA & DHA Omega-3 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
WHC
Viva
OmegaVia
WHC
Nutrigold
Omax3
The
Ocean
InnovixLabs
Controlled
Segment by Type
Capsule EPA
Powder EPA
Segment by Application
Infant Formula
Fortified Foods and Beverages
Nutritional Supplements
Pharmaceuticals
Clinical Nutrition
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the EPA & DHA Omega-3 market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of EPA & DHA Omega-3, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the EPA & DHA Omega-3 industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of EPA & DHA Omega-3 in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, EPA & DHA Omega-3 introduction, etc. EPA & DHA Omega-3 Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of EPA & DHA Omega-3 market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices